Immediate Impact

3 by Nobel laureates 5 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Colorectal cancer
2024 Standout
4 intermediate papers

Works of Martin Kornacker being referenced

ERA 223: A phase 3 trial of radium-223 dichloride (Ra-223) in combination with abiraterone acetate (abiraterone) and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone predominant metastatic castration-resistant prostate cancer (mCRPC).
2015
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study
2013

Author Peers

Author Last Decade Papers Cites
Martin Kornacker 561 310 293 397 372 58 1.2k
Rosaria De Filippi 455 443 284 376 297 61 1.1k
Anna Novarino 571 140 181 315 286 43 1.1k
Cynthia A. Sirard 371 440 458 467 226 43 1.0k
Thomas Melchardt 539 386 477 181 371 92 1.4k
Amit Nathwani 292 196 415 309 590 67 1.4k
Jane Starczynski 659 339 512 360 583 39 1.5k
Stefan Dirnhofer 520 524 304 285 358 88 1.6k
Oliver Bechter 573 182 196 230 749 93 1.7k
Matthew J. Barth 540 360 166 374 299 70 1.2k
A H Sarris 772 813 415 352 290 46 1.6k

All Works

Loading papers...

Rankless by CCL
2026